Conmed

Conmed EV/EBITDA

The EV/EBITDA (Enterprise Value to EBITDA) of Conmed (CNMD) as of Nov 13, 2026 is 13.43. In the previous year, EV/EBITDA (Enterprise Value to EBITDA) was 8.22 — a change of 63.33% (higher).

EV/EBITDA

13.43

YoY

63.33%

Last updated:

EV/EBITDA (Enterprise Value to EBITDA) of Conmed is 2025 13.43 . EV/EBITDA (Enterprise Value to EBITDA) of Conmed was 2024 8.22 . It decreases by 63.33% higher compared to the previous year.

The Conmed EV/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBITDA
Date
EV/EBITDA
Jan 1, 2018
15.77 USD
Jan 1, 2019
16.10 USD
Jan 1, 2020
22.15 USD
Jan 1, 2021
12.08 USD
Jan 1, 2022
20.02 USD
Jan 1, 2023
12.84 USD
Jan 1, 2024
8.22 USD
Jan 1, 2025
13.43 USD
The Conmed EV/EBITDA history
YEAREV/EBITDAYoY
13.43+63.33%
8.22-35.97%
12.84-35.85%
20.02+65.63%
12.08-45.46%
22.15+37.61%
16.10+2.10%
15.77-28.49%
22.05-16.43%
26.39+8.10%
24.41+5.10%
23.22—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Conmed Stock analysis

What does Conmed do? Conmed Corporation is a leading medical technology company that offers a wide range of surgical instruments and devices for the fields of gastroenterology, endoscopy, orthopedics, gynecology, and electro surgery. The company was founded in 1970 and is headquartered in Utica, New York. The history of Conmed Corp began with the founding of Consolidated Medical Equipment, Inc. (CME) in 1970. The company initially started its business with the distribution of surgical instruments and devices for medical applications and quickly expanded in this field. In the 1980s, the company went public. In the 1990s, the company changed its name to Conmed Corporation and expanded its activities into the field of electro surgery, which has since become a major growth driver for the company. Today, Conmed Corp operates multiple manufacturing facilities worldwide and has sales offices in over 50 countries. The company is divided into four main business segments: gastroenterology, endoscopy, orthopedics, and electro surgery. The gastroenterology segment includes products for the diagnosis and treatment of gastrointestinal disorders, such as endoscopes, biopsy instruments, dilation balloons, trocars, and shears. In the endoscopy segment, Conmed Corp offers products for the diagnosis and treatment of digestive tract disorders, including endoscopes, biopsy instruments, dilation balloons, trocars, and shears. The orthopedics segment includes a wide range of surgical instruments and devices for the treatment of musculoskeletal disorders, including implants, bandages, bone plates, intramedullary nails, and others. Finally, the electro surgery segment is the fastest-growing segment of Conmed Corp and includes a wide range of devices for precision surgery, including electrocautery, electro surgery, endoscopy, and laparoscopy devices. Conmed Corp aims to develop innovative medical technologies that meet the needs of patients and healthcare professionals. The company places great emphasis on producing high-quality products that are reliable and safe. Conmed Corp is a successful company that continues to evolve and expand its product range to meet the rapidly evolving needs of the medical community. Conmed is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Conmed stock

EV/EBITDA (Enterprise Value to EBITDA) of Conmed is 13.43 in 2025.

EV/EBITDA (Enterprise Value to EBITDA) of Conmed changed from 8.22 to 13.43, representing a 63.33% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/EBITDA (Enterprise Value to EBITDA) Conmed since 2006 – with annual values, charts, and detailed analysis.

The EV/EBITDA ratio is a widely used valuation metric that compares a company's enterprise value to its EBITDA. It normalizes for differences in capital structure, taxation, and depreciation policies.

To evaluate EV/EBITDA (Enterprise Value to EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBITDA (Enterprise Value to EBITDA).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBITDA (Enterprise Value to EBITDA)'s Conmed with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Conmed

All Key Metrics — Conmed